Temovate
NDC Package 0462-0293-60
Package Information
Temovate is a medication used to treat a variety of skin conditions (e.g., eczema, psoriasis, dermatitis, allergies, rash). Marketed by Pharmaderm, A Division Of Fougera Pharmaceuticals Inc., this product is identified by NDC 0462-0293 and is authorized under FDA application NDA020337.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0462 - Pharmaderm, A Division Of Fougera Pharmaceuticals Inc.
- 0462-0293 - Temovate
- 0462-0293-60 - 1 TUBE in 1 CARTON / 60 g in 1 TUBE
- 0462-0293 - Temovate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0462-0293-60 identifies a specific commercial package of 1 tube in 1 carton / 60 g in 1 tube of Temovate, labeled by Pharmaderm, A Division Of Fougera Pharmaceuticals Inc.. This product is billed per "GM" gram and contains an estimated amount of 60 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pharmaderm, A Division Of Fougera Pharmaceuticals Inc. on April 29, 1994. The current certification is valid through November 30, 2012.
What are the primary indications for this medication?
This medication is used to treat a variety of skin conditions (e.g., eczema, psoriasis, dermatitis, allergies, rash). Clobetasol reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a very strong (super-high-potency) corticosteroid.
How is this Pharmaderm, A Division Of Fougera Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00462029360. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.